M Silicon Biosystems

Innovative technologies and solutions for isolation, recovery & molecular characterization of pure, single rare cells. Read our Netiquette

[M Silicon Biosystems @SiliconBio]

PRESS RELEASE
Publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH
#CTC #HER2 #Liquidbiopsy #CELLSEARCH
https://t.co/qn4OPg1FBb

[M Silicon Biosystems @SiliconBio]

Register today to attend the webinar, "MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for
Minimally Invasive Molecular Characterization of Multiple Myeloma" presented by Ankit Dutta, PhD.
https://t.co/TPoqgCG2CO
#MultipleMyeloma #Myeloma #webinar

[M Silicon Biosystems @SiliconBio]

Still time to register for the FREE webinar "Extending the Liquid Biopsy Concept from Blood to Cerebrospinal Fluid" with Dr B. Polzer and C. Köstler, hosted by @EACRnews

https://t.co/0743wpUGT8
#webinar #cancerresearch #DCC #CSF #liquidbiopsy

[M Silicon Biosystems @SiliconBio]

New CELLSEARCH® data will be presented at AACR 2023 annual meeting highlights trailblazing contributions of liquid biopsies for cancer research.
Read the full release: https://t.co/5vyf4wEERV
#AACR23 #cancerresearch #artificialintelligence #liquidbiopsy

[M Silicon Biosystems @SiliconBio]

We are looking forward to connecting with old friends and colleagues while meeting new ones as well at the upcoming #AACR23 Annual meeting. Be sure to stop by our booth (#100) to learn how #CELLSEARCH and #DEPArray PLUS can enhance your #cancerresearch.

[M Silicon Biosystems @SiliconBio]

Register now for our upcoming webinar "Extending the Liquid Biopsy Concept from Blood to Cerebrospinal Fluid" with Dr B. Polzer and C. Köstler, hosted by @EACRnews
Register for free https://t.co/azEJxZQ3b4
#webinar #cancerresearch #DCC #CSF

[M Silicon Biosystems @SiliconBio]

March is #MultipleMyeloma awareness month. We join the global myeloma community to help increase awareness on this disease, the second most common blood cancer in the world with 230,000 people living with myeloma ww.
https://t.co/h8EspEaxPv

#MyelomaAction #wearemenarini

[M Silicon Biosystems @SiliconBio]

Don't miss your chance to attend the special webinar "Implications of #CMMC Counts in Multiple Myeloma Patient Monitoring" tomorrow February 28 at 11 AM EST
#multiplemyeloma #webinar
Save your spot today: https://t.co/G8HXSdzH3I

[M Silicon Biosystems @SiliconBio]

We offer the most comprehensive liquid biopsy workflow leveraging the highly sensitive CELLSEARCH® platform for CTC enumeration and enrichment and the DEPArray™ PLUS platform, for precise single-cell sorting and retrieval.
Discover more
https://t.co/7wd8rZRjbS

[M Silicon Biosystems @SiliconBio]

New STIC trial data shows longer overall survival for therapy selection based on CELLSEARCH® CTC count in patients with metastatic breast cancer
https://t.co/M671bgCW2Y

#CTC #breastcancer #SABCS22

[M Silicon Biosystems @SiliconBio]

Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH® System leading to genomic profiling of myeloma cells shows potential for non-invasive management of #MultipleMyeloma patients at early stages of disease
Full press release https://t.co/Cr0WSck81G
#ctc #CELLSEARCH

[M Silicon Biosystems @SiliconBio]

We are heading to San Antonio to attend #SABCS22!
Stop by our booth to discover the CELLSEARCH #CTC Test, a simple, actionable blood test that helps oncologists assess the prognosis of patients with metastatic breast cancer.
For more information see https://t.co/rZ7bRJNZPn

[M Silicon Biosystems @SiliconBio]

Single cell Whole Genome Amplification (WGA) in less than 4 hours.
Our #Ampli1 WGA is best in class for low allelic dropout, meaning your NGS analysis is accurate and reproducible every time. Special offer available.
Learn more https://t.co/Z7xEfor0zG
#WGA #NGS #singlecell

[M Silicon Biosystems @SiliconBio]

Discover VRNxT, the automated instrument for volume reduction, designed to standardize your rare cell analysis.
VRNxT adds precision and accuracy and minimize losses of precious cells.
https://t.co/9YHxIq84V5
#VolumeReduction #RareCells #SamplePrep

[M Silicon Biosystems @SiliconBio]

Lung cancers are the leading cause of cancer-related deaths globally.
This November, we honor those working to expand treatment options for lung cancers, those treating #NSCLC and #SCLC, and those that have battled lung cancers.
#LungAwarness #LungCancer

[M Silicon Biosystems @SiliconBio]

Join us in Phoenix at the AMP 2022 Annual Meetings & Expo!

Discover our Laboratory Services and new CELLSEARCH® CTC LDTs, a minimally invasive approach to follow cancer patients through the analysis of rare #CTCs.
#AMPath22 #LabService #FFPE

[M Silicon Biosystems @SiliconBio]

LAST CHANCE TO REGISTER for the webinar "Single cell analysis in tissue and liquid biopsy: the way to dissect cancer heterogeneity", TOMORROW at 4 pm CET
REGISTER HERE https://t.co/hIYvEU3aPQ

[M Silicon Biosystems @SiliconBio]

We are in Miami attending the ISLB annual meeting - Come meet us to discover why the CELLSEARCH® system continues to shine as the gold standard in liquid biopsy technology for the detection and enumeration of circulating tumor cells (CTCs).
#ISLB2022 #CTC #SingleCell

[M Silicon Biosystems @SiliconBio]

Save the date - EACR LIVE webinar on October 27
"Single cell analysis in tissue and liquid biopsy: the way to dissect cancer heterogeneity"
With Dr F Lessi, PhD, and Dr M Ignatiadis, MD, PhD
Register NOW https://t.co/IzHFr8K8DU
#EACR #webinar #singlecell

[M Silicon Biosystems @SiliconBio]

October is Breast Cancer #Awareness Month, an important occasion to raise awareness about the impact of breast cancer and share knowledge. We would like to recognize and thank the healthcare workers, caregivers, patients working together to battle this disease #BreastCancer